Endometrial thermoablation for treatment of menorrhagia: Comparison of two methods in outpatient setting

Acta Obstetricia et Gynecologica Scandinavica

Volumn 82, Issue 3, 2003, Pages 269-274

  Vihko, Kimmo ^a,b   Raitala, Reijo ^a,c   Taina, Esko ^a,c  

^a Depts of Obstetrics and Gynecology   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

Menorrhagia; Thermoablation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; ENDOMETRIUM; ENDOMETRIUM ABLATION; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; INTERMETHOD COMPARISON; MENORRHAGIA; MORPHOLOGY; OUTPATIENT; PATIENT ATTITUDE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TIME; TREATMENT OUTCOME; UTERUS BLEEDING; CATHETER ABLATION; COMPARATIVE STUDY; METHODOLOGY; PATIENT SATISFACTION;

ADULT; CATHETER ABLATION; ENDOMETRIUM; FEMALE; HUMANS; MENORRHAGIA; PATIENT SATISFACTION;

EID: 0037363828     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2003.00110.x     Document Type: Article

References (17)

1. Mäkinen J, Johansson J, Tomas C, Tomas E, Heinonen PK, Laatikainen T et al. Morbidity of 10110 hysterectomies by type of approach. Hum Reprod 2001; 16: 1473-8.
2. Irvine GA, Cameron IT. Medical management of dysfunctional uterine bleeding. Bailliers Best Pract Res Clin Obstet Gynaecol 1999; 13: 189-202.
3. Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2000; 2: CD000400.
4. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2000; 4: CD000249.
5. Turner E, Bowie P, McMullen KW, Kellock C. First-line management of menorrhagia: findings from a survey of general practitioners in Fourth Valley. Br J Fam Plann 2000; 26: 227-8.
6. Barrington JW, Bowen-Simpkins P. The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynecol 1997; 104: 614-6.
7. Gallinat A. Endometrial ablation by balloon coagulation. Contrib Gynecol Obstet 2000; 20: 137-44.
8. Kochli OR. Endometrial ablation in the year 2000 - do we have more methods than indications? Contrib Gynecol Obstet 2000; 20: 91-120.
9. Friberg Joergensen C, Ahlgren M. Endometrial thermal coagulation - degree of uterine fibrosis predicts treatment outcome. Gynecol Obstet Invest 1998; 45: 54-7.
10. Hawe JA, Phillips AG, Chien PF, Erian J, Garry R. Cavaterm thermal balloon ablation for the treatment of menorrhagia. Br J Obstet Gynecol 1999; 106: 1143.
11. Ulmsten U, Carstensen H, Falconer C, Holm L, Lanner L, Nilsson S et al. The safety and efficacy of MenoTreat, a new balloon device for therman endometrial ablation. Acta Obstet Gynecol Scand 2001; 80: 52-7.
12. Farquhar CM, Steiner CA. Hysterectomy trends in the United States 1990-97. Obstet Gynecol 2002; 99: 229-34.
13. Varila E, Wahlström T, Rauramo I. A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy. Fertil Steril 2001; 76: 969-73.
14. Tapper AM, Heinonen PK. Hysteroscopic endomyome-trial resection for the treatment of menorrhagia - follow-up of 86 cases. Eur J Obstet Gynecol Reprod Biol 1995; 62: 75-9.
15. Tapper AM, Heinonen PK. Comparison of hysteroscopic endometrial resection and laparoscopic assisted vaginal hysterectomy for the treatment of menorrhagia. Acta Obstet Gynecol Scand 1998; 77: 78-82.
16. Tapper AM, Heinonen PK. Experience with isotonic 2.2% glycine as distension medium for hysteroscopic endomyometrial resection. Gynecol Obstet Invest 1999; 47: 263-7.
17. Morrison BW, Christensen S, Yuan W, Brown J, Amlani S, Seidenberg B. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial. Clin Ther 1999; 21: 943-53.